The timeline depends on dose, tolerance, nutrition, activity, and follow-up consistency
He was sharing a patient story about how taking a GLP-1 gave them relief from the food noise, and I remember thinking, Thats exactly what Ive been fighting my entire life! I had already lost 100 pounds, twice , through diet and exercise, but I was still struggling with the last 40 pounds I wanted to lose to reach a healthier weight for my body
VSMC senescence induced by Ang II is another important aspect of VSMC dysfunction
Furthermore, in another meta-analysis [23], which excluded ELIXA [24] due to fact that lixisenatide is a short-acting GLP-1RA and all participants had acute coronary syndrome, GLP-1RAs were associated with significant reductions in MACE (HR 0.85, 95% CI 0.800.90), cardiovascular death (HR 0.85, 95% CI 0.780.93), stroke (HR 0.81, 95% CI 0.740.90), and myocardial infarction (HR 0.88, 95% CI 0.810.96) (Table 2)
Patients managing insulin resistance, prediabetes, or type 2 diabetes often see added benefits due to improved blood sugar control
